Pharmacokinetics and safety of BCD-021, bevacizumab biosimilar candidate, compared to Avastin in patients.
Sergey V. Orlov
No relevant relationships to disclose
Olga N. Burdaeva
No relevant relationships to disclose
Marina P. Nechaeva
No relevant relationships to disclose
Mikhail V. Kopp
No relevant relationships to disclose
Bogdan N. Kotiv
No relevant relationships to disclose
Ludmila P. Sheveleva
No relevant relationships to disclose
Oleg A. Gladkov
No relevant relationships to disclose
Andrey V. Khorinko
No relevant relationships to disclose
Tatiana I. Prokopenko
No relevant relationships to disclose
Julia S. Shapovalova
No relevant relationships to disclose
Irina A. Jelvakova
No relevant relationships to disclose
Nadezhda V. Kovalenko
No relevant relationships to disclose
Daniil L. Stroyakovsky
No relevant relationships to disclose
Aleksandr P. Pecheniy
No relevant relationships to disclose
R. Ivanov
No relevant relationships to disclose
Olga V. Filon
No relevant relationships to disclose
Sergei Tjulandin
No relevant relationships to disclose